A2 Beta-Casein Milk Protein Gut Microbiota Balance
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The composition of gut microbiota is often negatively influenced by the consumption of milk containing A1 beta-casein, leading to adverse health effects due to the production of BCM-7, which can cause inflammation and disrupt the balance of beneficial gut bacteria, whereas A2 beta-casein is associated with beneficially altered faecal levels of short-chain fatty acids.
Innovation Solution
A method and composition that predominantly includes A2 beta-casein or related variants, ensuring at least 75% by weight of beta-casein has a proline at position 67, thereby reducing or eliminating the production of BCM-7 and promoting the growth of beneficial gut bacteria, using milk and milk-derived products as primary sources.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If milk containing A1 beta-casein is consumed, then protein nutrition is provided, but BCM-7 is produced causing inflammation and disrupting gut bacteria balance
Solution Approach 1:
The invention extracts and eliminates the harmful A1 beta-casein variant from milk products, retaining only the A2 beta-casein variant. This selective removal prevents BCM-7 production while maintaining the nutritional protein content, directly resolving the contradiction between protein intake and harmful BCM-7 generation.
Solution Approach 2:
The invention changes the amino acid parameter at position 67 of beta-casein from histidine (A1 variant) to proline (A2 variant). This parameter change prevents the formation of BCM-7 during digestion while preserving the protein's nutritional value, thereby eliminating inflammation without sacrificing protein intake.
2Stability of the object's composition
If A1 beta-casein is present in milk, then standard milk composition is maintained, but beneficial gut microbiota levels are reduced
Solution Approach 1:
The invention removes the A1 beta-casein variant from milk composition while retaining A2 beta-casein, thereby preserving the overall milk composition stability while eliminating the harmful effect on gut microbiota. This selective extraction maintains product consistency without compromising microbial health.
Solution Approach 2:
The invention modifies the beta-casein variant composition parameter, ensuring that only A2 beta-casein (with proline at position 67) is present. This parameter change prevents the disruption of gut microbiota while maintaining standard milk composition characteristics.
3Reliability
If A2 beta-casein is used predominantly, then beneficial gut microbiota levels are enhanced, but production complexity increases
Solution Approach 1:
The invention utilizes the natural genetic capability of certain cattle breeds (such as A2 wholefarm cows) to produce milk containing predominantly A2 beta-casein. This self-service approach allows farmers to obtain A2-rich milk through selective breeding without requiring complex separation or processing technologies, thereby enhancing gut microbiota benefits while minimizing production complexity.
Solution Approach 2:
The invention changes the breeding parameter to select for A2 beta-casein producing cattle, which naturally produce milk with the desired protein composition. This parameter change in animal genetics simplifies the overall production system compared to implementing complex post-processing separation techniques.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enhances the levels of beneficial gut microbiota, as evidenced by increased levels of acetic acid, butanoic acid, and total short-chain fatty acids, potentially reducing the risk of various health issues such as cancer, liver disease, and metabolic syndrome.
Implementation Method 1
The presence of histidine at position 67 allows a protein fragment comprising seven amino acids, known as beta-casomorphin-7 (BCM-7), to be produced on enzymatic digestion of beta-caseins in the gut.
Implementation Method 2
One of the ways gut microorganisms benefit the host is by the fermentation of undigested carbohydrates and the subsequent production of short-chain fatty acids (SCFAs).
Data Source
AI summary
Improving the balance of beneficial gut microbiota of an animal by providing a composition containing beta-casein, wherein at least 75% by weight of the beta-casein is a beta-casein variant that has a proline at position 67 of the beta-casein amino acid sequence.